Founded in 1986, Datix is the market leader in the UK, with its software installed in more than 70 per cent of National Health Service hospitals. Its products are also used by major healthcare providers worldwide.
Risk management systems are an important tool by which healthcare institutions can monitor quality of care, control costs and minimise reputational damage. They can also help hospitals to meet regulatory requirements.
Datix’s software creates a comprehensive picture of a healthcare organisation’s risks by integrating information from patient safety incidents with complaints, claims and health and safety incidents. Greater visibility of this information means hospitals can make appropriate improvements to reduce risks and increase safety for patients and staff.
With an expanding customer base and the development of enhanced products, Datix’s annual turnover has grown by more than 20 per cent per annum over the past three years. Joint Managing Director, Jonathan Hazan says: "With Bowmark’s support, we will continue to develop our position as a leader in the global marketplace, at the same time as enhancing our existing products and adapting our software for use as a risk management tool in other sectors."
Joint Managing Directors, Jonathan Hazan and Daniel Hazan will lead the buyout. Founder Brian Capstick will remain an investor in the company, and will become a non-executive director.
Under our ownership, Datix rolled-out its patient safety and risk management software to public and private healthcare organisations across the US, Europe and Australia
In the news
20 February 2024
Shortlist announced for the 2024 Megabuyte50 Awards, sponsored by Bowmark
15 February 2024
Bowmark Capital invests in CubeLogic